Laronde

Closed

Cambridge, United States · Founded 2017 · $490.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$490.0M
Last Round
$440.0M Series BAug 2021
Rounds
2

About

Laronde is a biotechnology company pioneering Endless RNA (eRNA), a completely novel class of engineered RNA that can be programmed to express diverse proteins inside the body. Unlike conventional mRNA, eRNA is persistent, non-immunogenic, and supports repeat dosing with flexibility in formulation and delivery, enabling durable protein expression for a broad range of diseases. Founded in 2017 by Flagship Labs, the innovation foundry of Flagship Pioneering, Laronde is developing multiple therapeutic programs in parallel across many disease areas from its Cambridge, Massachusetts headquarters.

Summary

Laronde is a Biotech company based in Cambridge, United States, founded in 2017. It has raised $490.0M in total across 2 rounds, most recently a $440.0M Series B round in Aug 2021. Investors include Flagship Pioneering, Fidelity Management and T. Rowe Price.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BAug 2021
$440.0M

Sign up to see all 2 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Laronde on Indexed.vc
<a href="https://indexed.vc/companies/laronde"><img src="https://indexed.vc/api/badge/company/laronde" alt="Laronde on Indexed.vc" width="260" height="76" /></a>